Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial von Colevas, A.D., Bahleda, R., Braiteh, F., Balmanoukian, A., Brana, I., Chau, N.G., Sarkar, I., Molinero, L., Grossman, W., Kabbinavar, F., Fassò, M., O’Hear, C., Powderly, J.

Volltext

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer von KABBINAVAR, Fairooz F, HAMBLETON, Julie, MASS, Robert D, HURWITZ, Herbert I, BERGSLAND, Emily, SARKAR, Somnath

Volltext

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005 von Ji, Yongli, Rankin, Cathryn, Grunberg, Steven, Sherrod, Andy E, Ahmadi, Jamshid, Townsend, Jeannette J, Feun, Lynn G, Fredericks, Ruth K, Russell, Christy A, Kabbinavar, Fairooz F, Stelzer, Keith J, Schott, Anne, Verschraegen, Claire

Volltext

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial von Mansfield, A.S., Każarnowicz, A., Karaseva, N., Sánchez, A., De Boer, R., Andric, Z., Reck, M., Atagi, S., Lee, J.-S., Garassino, M., Liu, S.V., Horn, L., Wen, X., Quach, C., Yu, W., Kabbinavar, F., Lam, S., Morris, S., Califano, R.

Volltext

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial von KABBINAVAR, Fairooz F, SCHULZ, Joseph, MCCLEOD, Michael, PATEL, Taral, HAMM, John T, HECHT, J. Randolph, MASS, Robert, PERROU, Brent, NELSON, Betty, NOVOTNY, William F

Volltext

Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials von KABBINAVAR, Fairooz F, HURWITZ, Herbert I, JING YI, SARKAR, Somnath, ROSEN, Oliver

Volltext

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findin... von Shi, Qian, de Gramont, Aimery, Grothey, Axel, Zalcberg, John, Chibaudel, Benoist, Schmoll, Hans-Joachim, Seymour, Matthew T, Adams, Richard, Saltz, Leonard, Goldberg, Richard M, Punt, Cornelis J A, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Hurwitz, Herbert, Díaz-Rubio, Eduardo, Porschen, Rainer, Tebbutt, Niall C, Fuchs, Charles, Souglakos, John, Falcone, Alfredo, Tournigand, Christophe, Kabbinavar, Fairooz F, Heinemann, Volker, Van Cutsem, Eric, Bokemeyer, Carsten, Buyse, Marc, Sargent, Daniel J

Volltext

Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer von BUKOWSKI, Ronald M, KABBINAVAR, Fairooz F, SCAPPATICCI, Frank A, MCDERMOTT, David, FIGLIN, Robert A, FLAHERTY, Keith, SRINIVAS, Sandy, VAISHAMPAYAN, Ulka, DRABKIN, Harry A, DUTCHER, Janice, RYBA, Sarah, QI XIA

Volltext

Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma von KLATTE, Tobias, NAGESH RAO, P, DE MARTINO, Michela, LAROCHELLE, Jeffrey, SHUCH, Brian, ZOMORODIAN, Nazy, SAID, Jonathan, KABBINAVAR, Fairooz F, BELLDEGRUN, Arie S, PANTUCK, Allan J

Volltext

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database... von Renfro, Lindsay A, Goldberg, Richard M, Grothey, Axel, Sobrero, Alberto, Adams, Richard, Seymour, Matthew T, Heinemann, Volker, Schmoll, Hans-Joachim, Douillard, Jean-Yves, Hurwitz, Herbert, Fuchs, Charles S, Diaz-Rubio, Eduardo, Porschen, Rainer, Tournigand, Christophe, Chibaudel, Benoist, Hoff, Paulo M, Kabbinavar, Fairooz F, Falcone, Alfredo, Tebbutt, Niall C, Punt, Cornelis J A, Hecht, J Randolph, Souglakos, John, Bokemeyer, Carsten, Van Cutsem, Eric, Saltz, Leonard, de Gramont, Aimery, Sargent, Daniel J

Volltext

Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy von KLATTE, Tobias, SELIGSON, David B, LAROCHELLE, Jeffrey, SHUCH, Brian, SAID, Jonathan W, RIGGS, Stephen B, ZOMORODIAN, Nazy, KABBINAVAR, Fairooz F, PANTUCK, Allan J, BELLDEGRUN, Arie S

Volltext

Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma von KLATTE, Tobias, PANTUCK, Allan J, SAID, Jonathan W, SELIGSON, David B, RAO, Nagesh P, LAROCHELLE, Jeffrey C, SHUCH, Brian, ZISMAN, Amnon, KABBINAVAR, Fairooz F, BELLDEGRUN, Arie S

Volltext

Hypoxia-Inducible Factor 1α in Clear Cell Renal Cell Carcinoma von Klatte, Tobias, Seligson, David B, Riggs, Stephen B, Leppert, John T, Berkman, Maria K, Kleid, Mark D, Yu, Hong, Kabbinavar, Fairooz F, Pantuck, Allan J, Belldegrun, Arie S

Volltext

Phase Ib study of tivozanib (AV-951) in combination with temsirolimus in patients with renal cell carcinoma von Fishman, M.N, Srinivas, S, Hauke, R.J, Amato, R.J, Esteves, B, Cotreau, M.M, Strahs, A.L, Slichenmyer, W.J, Bhargava, P, Kabbinavar, F.F

Volltext

Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm von Shuch, Brian, Riggs, Stephen B., LaRochelle, Jeff C., Kabbinavar, Fairooz F., Avakian, Raffi, Pantuck, Allan J., Patard, Jean‐Jacques, Belldegrun, Arie S.

Volltext

Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the Urothelium von Sweeney, Christopher J, Roth, Bruce J, Kabbinavar, Fairooz F, Vaughn, David J, Arning, Michael, Curiel, Rafael E, Obasaju, Coleman K, Wang, Yanping, Nicol, Steven J, Kaufman, Donald S

Volltext

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project von Sjoquist, Katrin M, Renfro, Lindsay A, Simes, R John, Tebbutt, Niall C, Clarke, Stephen, Seymour, Matthew T, Adams, Richard, Maughan, Timothy S, Saltz, Leonard, Goldberg, Richard M, Schmoll, Hans-Joachim, Van Cutsem, Eric, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Tournigand, Christophe, Punt, Cornelis J A, Koopman, Miriam, Hurwitz, Herbert, Heinemann, Volker, Falcone, Alfredo, Porschen, Rainer, Fuchs, Charles, Diaz-Rubio, Eduardo, Aranda, Enrique, Bokemeyer, Carsten, Souglakos, Ioannis, Kabbinavar, Fairooz F, Chibaudel, Benoist, Meyers, Jeffrey P, Sargent, Daniel J, de Gramont, Aimery, Zalcberg, John R

Volltext

Smoking negatively impacts renal cell carcinoma overall and cancer‐specific survival von Kroeger, Nils, Klatte, Tobias, Birkhäuser, Frédéric D., Rampersaud, Edward N., Seligson, David B., Zomorodian, Nazy, Kabbinavar, Fairooz F., Belldegrun, Arie S., Pantuck, Allan J.

Volltext

IMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN) von Haddad, R., Wong, D.J., Guo, Y., Fayette, J., Cohen, E.E.W., Kowgier, M., Sandler, A., Matheny, C., Kabbinavar, F., Raben, D.

Volltext

IMpower133: Primary efficacy and safety + CNS-related adverse events in a phase I/III study of first-line (1L) atezolizumab + carboplatin + etoposide in extensive-stage SCLC (ES-SC... von Mok, T.S.K., Reck, M., Horn, L., Lam, S., Shames, D.S., Liu, J., Kabbinavar, F., Lin, W., Sandler, A., Liu, S.V.

Volltext